Brazil · Delayed Price · Currency is BRL Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of BRL 1.08 trillion. The enterprise value is 1.17 trillion.
| Market Cap | 1.08T |
| Enterprise Value | 1.17T |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.34% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 28.07% |
| Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 12.22 and the forward PE ratio is 13.98.
| PE Ratio | 12.22 |
| Forward PE | 13.98 |
| PS Ratio | 4.05 |
| PB Ratio | 6.45 |
| P/TBV Ratio | 19.57 |
| P/FCF Ratio | 21.24 |
| P/OCF Ratio | 10.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.15, with an EV/FCF ratio of 22.92.
| EV / Earnings | 13.19 |
| EV / Sales | 4.59 |
| EV / EBITDA | 9.15 |
| EV / EBIT | 10.08 |
| EV / FCF | 22.92 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.80 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 2.22 |
| Interest Coverage | 33.42 |
Financial Efficiency
Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 41.13%.
| Return on Equity (ROE) | 60.70% |
| Return on Assets (ROA) | 17.43% |
| Return on Invested Capital (ROIC) | 41.13% |
| Return on Capital Employed (ROCE) | 42.97% |
| Weighted Average Cost of Capital (WACC) | 6.09% |
| Revenue Per Employee | 3.87M |
| Profits Per Employee | 1.28M |
| Employee Count | 78,554 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, Novo Nordisk has paid 24.34 billion in taxes.
| Income Tax | 24.34B |
| Effective Tax Rate | 21.53% |
Stock Price Statistics
The stock price has decreased by -49.98% in the last 52 weeks. The beta is 0.40, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -49.98% |
| 50-Day Moving Average | 35.79 |
| 200-Day Moving Average | 40.16 |
| Relative Strength Index (RSI) | 35.34 |
| Average Volume (20 Days) | 116,338 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of BRL 267.62 billion and earned 88.70 billion in profits. Earnings per share was 19.94.
| Revenue | 267.62B |
| Gross Profit | 220.54B |
| Operating Income | 121.76B |
| Pretax Income | 113.04B |
| Net Income | 88.70B |
| EBITDA | 132.74B |
| EBIT | 121.76B |
| Earnings Per Share (EPS) | 19.94 |
Balance Sheet
The company has 23.35 billion in cash and 113.40 billion in debt, with a net cash position of -90.05 billion.
| Cash & Cash Equivalents | 23.35B |
| Total Debt | 113.40B |
| Net Cash | -90.05B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 168.03B |
| Book Value Per Share | 37.81 |
| Working Capital | -37.41B |
Cash Flow
In the last 12 months, operating cash flow was 103.13 billion and capital expenditures -52.08 billion, giving a free cash flow of 51.06 billion.
| Operating Cash Flow | 103.13B |
| Capital Expenditures | -52.08B |
| Free Cash Flow | 51.06B |
| FCF Per Share | n/a |
Margins
Gross margin is 82.41%, with operating and profit margins of 45.50% and 33.14%.
| Gross Margin | 82.41% |
| Operating Margin | 45.50% |
| Pretax Margin | 42.24% |
| Profit Margin | 33.14% |
| EBITDA Margin | 49.60% |
| EBIT Margin | 45.50% |
| FCF Margin | 19.08% |
Dividends & Yields
This stock pays an annual dividend of 0.87, which amounts to a dividend yield of 2.79%.
| Dividend Per Share | 0.87 |
| Dividend Yield | 2.79% |
| Dividend Growth (YoY) | 34.48% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 50.53% |
| Buyback Yield | 0.34% |
| Shareholder Yield | 3.14% |
| Earnings Yield | 8.18% |
| FCF Yield | 4.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 20, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 20, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 5.15 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.15 |
| Piotroski F-Score | 5 |